Myomo, Inc. (MYO) vs Talis Biomedical Corporation (TLIS)
- Myomo, Inc. MYO 1.20 −7.69%
- Talis Biomedical Corporation TLIS 2.84 0.00%
Myomo, Inc. and Talis Biomedical Corporation are both Medical Devices companies. Myomo, Inc. is the larger, with a market value of $51.5M against $46.3M — 1.1× the size. Myomo, Inc. grew revenue faster over the last twelve months: 6.14% against −65.2%. Talis Biomedical Corporation has the higher net margin (0.00% vs −33.5%) and the higher return on invested capital (0.00% vs −167.9%). Across the 18 metrics below, Talis Biomedical Corporation leads on 11 and Myomo, Inc. on 7.
Valuation
Profitability
| Metric | MYO | TLIS | Medical Devices median |
|---|---|---|---|
| Gross margin | 68.35% | 97.27% | 56.01% |
| Operating margin | (27.05%) | 0.00% | (15.03%) |
| Net margin | (33.53%) | 0.00% | (20.40%) |
| Free cash flow margin | (21.01%) | 0.00% | (7.24%) |
| Return on equity | (123.76%) | (70.48%) | (15.32%) |
| Return on assets | (39.20%) | (52.13%) | (19.72%) |
| Return on invested capital | (167.90%) | 0.00% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack